Guangzhou Baiyunshan Pharmaceutical Holdings (00874): Guanghua Pharmaceutical and Tonghe Street Office sign land acquisition and compensation agreement.
Baiyun Mountain (00874) announces that its subsidiary Guanghua Pharmaceutical, located at No. 355 Shatai North Road, Baiyun District, Guangzhou City, has been included in the "Baiyun Tonghe Area Land Reserve Implementation Plan". On November 27, 2025, Guanghua Pharmaceutical signed a land acquisition compensation agreement with Tonghe Subdistrict Office. According to the agreement, the compensation amount for this land acquisition is RMB 375 million. If the land meets the "net land" standard and other conditions, an additional land transfer reward of approximately RMB 73.3238 million can be obtained, making the total compensation and land transfer reward approximately RMB 449 million.
Guangzhou Baiyunshan Pharmaceutical Holdings (00874) announced that its subsidiary, Guanghua Pharmaceutical, located at No. 355 North Shatai Road, Baiyun District, Guangzhou, has been included in the "Baiyun Tonghe Area Land Reserve Implementation Plan" for the purpose of land acquisition. On November 27, 2025, Guanghua Pharmaceutical entered into a land acquisition compensation agreement with the Tonghe Street Office. According to the agreement, the compensation amount for this land acquisition is 375 million RMB. If the land meets the criteria for "net land," an additional land acquisition reward of approximately 73.3238 million RMB can be obtained. The total compensation and land acquisition reward amount to approximately 449 million RMB.
Related Articles

China Securities Co., Ltd. (06066): "22 Xin Investment G5" will pay interest on December 8th.

Luk Fook Holdings (00590) releases interim results, with a net profit attributable to shareholders of HK$619 million, up 42.5% year-on-year.

China Securities Co., Ltd. (06066): "22 Xin Investment G4" will be redeemed and delisted on December 8th.
China Securities Co., Ltd. (06066): "22 Xin Investment G5" will pay interest on December 8th.

Luk Fook Holdings (00590) releases interim results, with a net profit attributable to shareholders of HK$619 million, up 42.5% year-on-year.

China Securities Co., Ltd. (06066): "22 Xin Investment G4" will be redeemed and delisted on December 8th.

RECOMMEND

Food Delivery Ceasefire: Chinese Concept Stocks Reach Dual Inflection In Value And Technology — From Cash‑Burning Rivalry To An AI‑Led Strategic Upgrade
27/11/2025

Six Departments Issue Joint Plan To Boost Consumption And Improve Supply‑Demand Alignment For Consumer Goods
27/11/2025

Citi Research On China’s Humanoid Robot Industry: Broad Optimism, Exponential Growth Likely In 2026, At Least A Doubling
27/11/2025


